Dranitsaris, George; Phillips, Peter; Rotstein, Coleman; … - In: PharmacoEconomics 13 (1998) 5, pp. 509-518
Fluconazole (FLU) is an alternative to amphotericin B (AMB) for the treatment of candidemia in non-neutropenic patients. This agent has similar clinical efficacy but significantly reduced adverse effects compared with AMB. Using the database from a Canadian randomised multicentre comparative...